- MARMarriott$102BReported
MARQ2 2020
Marriott
View full reportEPS
Estimated
-$0.44
Actual
-$0.6445.5%
Revenue
Estimated
$960.8M
Actual
$1.5B52.4%
- DUKDuke Energy$96.5BReported
DUKQ2 2020
Duke Energy
View full reportEPS
Estimated
$1.04
Actual
$1.083.8%
Revenue
Estimated
$5.2B
Actual
$5.3B3.2%
- MELIMercadoLibre$86.0BReported
MELIQ2 2020
MercadoLibre
View full reportEPS
Estimated
$0.09
Actual
$1.111133.3%
Revenue
Estimated
$71.2M
Actual
$878.4M1133.3%
- RCLRoyal Caribbean$75.4BReported
RCLQ2 2020
Royal Caribbean
View full reportEPS
Estimated
-$4.71
Actual
-$6.1330.1%
Revenue
Estimated
$138.1M
Actual
$175.6M27.2%
- BBarrick$69.8BReported
BQ2 2020
Barrick
View full reportEPS
Estimated
$0.18
Actual
$0.2327.8%
Revenue
Estimated
$2.4B
Actual
$1.1B55.8%
- SPGSimon$67.1BReported
SPGQ2 2020
Simon
View full reportEPS
Estimated
$2.31
Actual
$2.128.2%
Revenue
Estimated
$265.5M
Actual
$1.1B300.0%
- OXYOccidental$57.0BReported
OXYQ2 2020
Occidental
View full reportEPS
Estimated
-$1.66
Actual
-$1.766.0%
Revenue
Estimated
$2.8B
Actual
$2.9B3.6%
- RVMDRevolution Medicines$32.9BReported
RVMDQ2 2020
Revolution Medicines
View full reportEPS
Estimated
-$0.34
Actual
-$0.4635.3%
Revenue
Estimated
$7.8M
Actual
$10.0M27.8%
- PPLPPL$26.6BReported
PPLQ2 2020
PPL
View full reportEPS
Estimated
$0.55
Actual
$0.550.0%
Revenue
Estimated
$1.7B
Actual
$1.7B0.0%
- FWONKLiberty Formula One$22.8BReported
FWONKQ2 2020
Liberty Formula One
View full reportEPS
Estimated
—
Actual
—
Revenue
Estimated
—
Actual
$1.9B
- YPFYPF$20.4BReported
YPFQ2 2020
YPF
View full reportEPS
Estimated
-$0.83
Actual
-$2.68222.9%
Revenue
Estimated
$14.4M
Actual
$1.7B11409.8%
- IFFIFF$19.9BReported
IFFQ2 2020
IFF
View full reportEPS
Estimated
$1.33
Actual
$1.362.3%
Revenue
Estimated
$1.2B
Actual
$1.2B3.8%
- LITELumentum$67.0BReported
LITEQ4 2020
Lumentum
View full reportEPS
Estimated
$0.83
Actual
$1.1842.2%
Revenue
Estimated
$258.9M
Actual
$368.1M42.2%
- SYYSysco$36.3BReported
SYYQ4 2020
Sysco
View full reportEPS
Estimated
-$0.39
Actual
-$0.2925.6%
Revenue
Estimated
$9.2B
Actual
$8.9B3.3%
- SMCISupermicro$24.8BReported
SMCIQ4 2020
Supermicro
View full reportEPS
Estimated
$0.05
Actual
$0.0736.0%
Revenue
Estimated
$711.6M
Actual
$896.1M25.9%
- BNTXBioNTech SE$23.6BReported
BNTXQ2 2020
BioNTech SE
View full reportEPS
Estimated
-$0.29
Actual
-$0.4244.8%
Revenue
Estimated
$40.0M
Actual
$46.0M14.9%
- EXEChesapeake$22.4BReported
EXEQ2 2020
Chesapeake
View full reportEPS
Estimated
$0.00
Actual
-$28.22
Revenue
Estimated
$0.00
Actual
$521.0M
- JHXJames Hardie$18.0BReported
JHXQ1 2021
James Hardie
View full reportEPS
Estimated
—
Actual
$0.01
Revenue
Estimated
—
Actual
$626.3M
- BRBroadridge$17.3BReported
BRQ4 2020
Broadridge
View full reportEPS
Estimated
$2.09
Actual
$2.152.9%
Revenue
Estimated
$1.3B
Actual
$1.4B2.9%
- BBIOBridgebio$13.4BReported
BBIOQ2 2020
Bridgebio
View full reportEPS
Estimated
-$0.79
Actual
-$1.0330.4%
Revenue
Estimated
—
Actual
—
- NIONio$12.9BReported
NIOQ2 2020
Nio
View full reportEPS
Estimated
-$0.34
Actual
-$0.1555.9%
Revenue
Estimated
$6.3B
Actual
$526.4M91.7%
- VIAVViavi$11.9BReported
VIAVQ4 2020
Viavi
View full reportEPS
Estimated
$0.14
Actual
$0.1828.6%
Revenue
Estimated
$192.5M
Actual
$266.6M38.5%
- XPXP$8.8BReported
XPQ2 2020
XP
View full reportEPS
Estimated
$0.12
Actual
$0.1958.3%
Revenue
Estimated
$1.4B
Actual
$357.9M74.0%
- COGTCogent Biosciences$6.0BReported
COGTQ2 2020
Cogent Biosciences
View full reportEPS
Estimated
-$0.84
Actual
-$0.9614.3%
Revenue
Estimated
$452.6K
Actual
$528.0K16.7%
- MACMacerich$6.0BReported
MACQ2 2020
Macerich
View full reportEPS
Estimated
$0.46
Actual
$0.3915.2%
Revenue
Estimated
$297.6M
Actual
$178.6M40.0%
- LRNStride$3.9BReported
LRNQ4 2020
Stride
View full reportEPS
Estimated
$0.03
Actual
$0.311027.3%
Revenue
Estimated
$67.2M
Actual
$268.9M300.0%
- CSCOCisco$468BReported
CSCOQ4 2020
Cisco
View full reportEPS
Estimated
$0.74
Actual
$0.808.1%
Revenue
Estimated
$11.2B
Actual
$12.2B8.1%
- WPMWheaton Precious Metals$59.1BReported
WPMQ2 2020
Wheaton Precious Metals
View full reportEPS
Estimated
$0.19
Actual
$0.2215.8%
Revenue
Estimated
$222.7M
Actual
$248.0M11.3%
- APGAPi Group$18.2BReported
APGQ2 2020
APi Group
View full reportEPS
Estimated
$0.18
Actual
$0.3277.8%
Revenue
Estimated
$333.4M
Actual
$889.0M166.7%
- PFGCPFG$15.3BReported
PFGCQ4 2020
PFG
View full reportEPS
Estimated
-$0.25
Actual
-$0.86246.6%
Revenue
Estimated
$1.7B
Actual
$5.8B244.0%
- ZTOZTO Express$12.5BReported
ZTOQ2 2020
ZTO Express
View full reportEPS
Estimated
$0.28
Actual
$0.267.1%
Revenue
Estimated
$6.5B
Actual
$906.2M86.0%
- CACICACI$11.6BReported
CACIQ4 2020
CACI
View full reportEPS
Estimated
$3.44
Actual
$3.687.0%
Revenue
Estimated
$1.4B
Actual
$1.5B7.0%
- AITApplied Industrial Technologies$11.4BReported
AITQ4 2020
Applied Industrial Technologies
View full reportEPS
Estimated
$0.68
Actual
$0.8017.6%
Revenue
Estimated
$616.3M
Actual
$725.1M17.6%
- ENSEnerSys$8.3BReported
ENSQ1 2021
EnerSys
View full reportEPS
Estimated
$0.67
Actual
$0.9237.3%
Revenue
Estimated
$513.4M
Actual
$704.9M37.3%
- PCVXVaxcyte$7.4BReported
PCVXQ2 2020
Vaxcyte
View full reportEPS
Estimated
-$1.27
Actual
-$1.7235.4%
Revenue
Estimated
—
Actual
—
- IMVTImmunovant$6.9BReported
IMVTQ1 2021
Immunovant
View full reportEPS
Estimated
-$0.35
Actual
-$0.388.6%
Revenue
Estimated
$0.00
Actual
—
- BRFSBRF$6.1BReported
BRFSQ2 2020
BRF
View full reportEPS
Estimated
$0.07
Actual
$0.070.0%
Revenue
Estimated
$11.1B
Actual
$1.7B84.8%
- EATBrinker Intl.$6.0BReported
EATQ4 2020
Brinker Intl.
View full reportEPS
Estimated
-$1.47
Actual
-$0.8840.1%
Revenue
Estimated
$876.8M
Actual
$563.2M35.8%
- AMATApplied Materials$357BReported
AMATQ3 2020
Applied Materials
View full reportEPS
Estimated
$0.95
Actual
$1.0611.6%
Revenue
Estimated
$3.9B
Actual
$4.4B11.6%
- NTESNetEase$79.2BReported
NTESQ2 2020
NetEase
View full reportEPS
Estimated
$0.75
Actual
$1.1350.7%
Revenue
Estimated
$13.9B
Actual
$2.6B81.4%
- BAMBrookfield$78.3BReported
BAMQ2 2020
Brookfield
View full reportEPS
Estimated
$0.39
Actual
-$0.43210.3%
Revenue
Estimated
$14.0B
Actual
$12.8B8.4%
- ASTSAST SpaceMobile$39.8BReported
ASTSQ2 2020
AST SpaceMobile
View full reportEPS
Estimated
—
Actual
-$0.19
Revenue
Estimated
—
Actual
$402.0K
- BIDUBaidu$36.7BReported
BIDUQ2 2020
Baidu
View full reportEPS
Estimated
$1.37
Actual
$2.0851.8%
Revenue
Estimated
$3.7B
Actual
$3.7B0.1%
- TPRTapestry$29.4BReported
TPRQ4 2020
Tapestry
View full reportEPS
Estimated
-$0.48
Actual
-$0.2547.9%
Revenue
Estimated
$1.6B
Actual
$714.8M55.4%
- WCCWESCO$17.7BReported
WCCQ2 2020
WESCO
View full reportEPS
Estimated
$0.66
Actual
$1.0457.6%
Revenue
Estimated
$1.6B
Actual
$2.1B31.7%
- AHRAmerican Healthcare REIT Inc$10.2BReported
AHRQ2 2020
American Healthcare REIT Inc
View full reportEPS
Estimated
—
Actual
—
Revenue
Estimated
—
Actual
$38.7M
- FUTUFutu$10.0BReported
FUTUQ2 2020
Futu
View full reportEPS
Estimated
$0.10
Actual
$0.24141.6%
Revenue
Estimated
$83.2M
Actual
$88.7M6.7%
- DDSDillard's$9.5BReported
DDSQ2 2020
Dillard's
View full reportEPS
Estimated
-$4.54
Actual
-$0.3791.9%
Revenue
Estimated
$12.3B
Actual
$945.2M92.3%
- PECOPhillips Edison$5.1BReported
PECOQ2 2020
Phillips Edison
View full reportEPS
Estimated
—
Actual
—
Revenue
Estimated
—
Actual
$119.0M
- GLNGGolar LNG$5.0BReported
GLNGQ2 2020
Golar LNG
View full reportEPS
Estimated
-$0.10
Actual
-$1.591490.0%
Revenue
Estimated
$62.9M
Actual
$102.2M62.5%
- DKNGDraftKings$12.2BReported
DKNGQ2 2020
DraftKings
View full reportEPS
Estimated
-$0.15
Actual
-$0.55266.7%
Revenue
Estimated
$78.0M
Actual
$70.9M9.1%
- VRNAVerona Pharma$9.1BReported
VRNAQ2 2020
Verona Pharma
View full reportEPS
Estimated
-$0.40
Actual
-$0.7280.0%
Revenue
Estimated
$0.00
Actual
—
- MSGSMSG Sports$8.9BReported
MSGSQ4 2020
MSG Sports
View full reportEPS
Estimated
-$1.77
Actual
-$3.2684.2%
Revenue
Estimated
$412.4M
Actual
-$7.0M101.7%
- MARAMarathon Digital$5.4BReported
MARAQ2 2020
Marathon Digital
View full reportEPS
Estimated
—
Actual
-$0.11
Revenue
Estimated
—
Actual
$286.2K
- SPHRSphere Entertainment Co$3.3BReported
SPHRQ4 2020
Sphere Entertainment Co
View full reportEPS
Estimated
-$4.97
Actual
$0.72114.5%
Revenue
Estimated
$3.6M
Actual
$9.0M149.4%
- ELVNEnliven Therapeutics$2.5BReported
ELVNQ2 2020
Enliven Therapeutics
View full reportEPS
Estimated
-$2.25
Actual
-$2.364.9%
Revenue
Estimated
—
Actual
—
- AHGHexindai$1.3BReported
AHGQ1 2021
Hexindai
View full reportEPS
Estimated
-$0.18
Actual
-$1.44700.2%
Revenue
Estimated
$7.2M
Actual
$876.8K87.8%
- ATLCAtlanticus$1.3BReported
ATLCQ2 2020
Atlanticus
View full reportEPS
Estimated
$0.00
Actual
$1.28
Revenue
Estimated
$0.00
Actual
$90.8M
- BFLYButterfly$1.2BReported
BFLYQ2 2020
Butterfly
View full reportEPS
Estimated
$0.00
Actual
-$3.78
Revenue
Estimated
$0.00
Actual
$11.8M
- PSIXPower Solutions International Inc$968MReported
PSIXQ2 2020
Power Solutions International Inc
View full reportEPS
Estimated
—
Actual
-$0.78
Revenue
Estimated
—
Actual
$93.1M